-
1
المؤلفون: Max Lataillade, Marcelo Martins, Peter Ackerman, Isabel Cassetti, Michael J. Kozal, Eduardo Sprinz, Jean-Michel Molina, Gilles Pialoux, Antonella Castagna, Moti Ramgopal, Gulam H Latiff, Amy Pierce, Princy Kumar, Adrian Streinu-Cercel, Shiven Chabria, Judith A. Aberg, Sandra Treviño-Pérez, Marcia Wang, Melanie Thompson, Cyril Llamoso
المساهمون: Ackerman, P., Thompson, M., Molina, J. -M., Aberg, J., Cassetti, I., Kozal, M., Castagna, A., Martins, M., Ramgopal, M., Sprinz, E., Trevino-Perez, S., Streinu-Cercel, A., Latiff, G. H., Pialoux, G., Kumar, P. N., Wang, M., Chabria, S., Pierce, A., Llamoso, C., Lataillade, M.
المصدر: AIDS (London, England)
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGSمصطلحات موضوعية: 0301 basic medicine, heavily treatment-experienced, Antirretrovirais, optimized background therapy, Human immunodeficiency virus (HIV), Phases of clinical research, HIV Infections, medicine.disease_cause, Piperazines, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, Resistência a medicamentos, education.field_of_study, Multiple antiretroviral drug resistance, Viral Load, Clinical Science, Organophosphates, antiretroviral agents, Infectious Diseases, Fostemsavir, Treatment Outcome, Cohort, Viral load, Adult, medicine.medical_specialty, Anti-HIV Agents, Immunology, Population, Optimized background therapy, Treatment experienced, 03 medical and health sciences, susceptibility score, Internal medicine, Humans, Adverse effect, education, fostemsavir, attachment inhibitor, business.industry, multiple antiretroviral drug resistance, Heavily treatment-experienced, Antiretroviral agents, CD4 Lymphocyte Count, 030104 developmental biology, Fármacos anti-HIV, HIV-1, Attachment inhibitor, business, Susceptibility score
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00eba98b1c2d2424aa242dd17969d5d
https://pubmed.ncbi.nlm.nih.gov/33946085 -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Cozzi-Lepri, A., Zangerle, R., Machala, L., Zilmer, K., Ristola, M., Pradier, C., Kirk, O., Sambatakou, H., Fatkenheuer, G., Yust, I., Schmid, P., Gottfredsson, M., Khromova, I., Jilich, D., Flisiak, R., Smidt, J., Rozentale, B., Radoi, R., Losso, M. H., Lundgren, J. D., Mocroft, A., Kundro, M., Schmied, B., Karpov, I., Vassilenko, A., Mitsura, V. M., Paduto, D., Clumeck, N., De Wit, S., Delforge, M., Florence, E., Vandekerckhove, L., Hadziosmanovic, V., Begovac, J., Sedlacek, D., Kronborg, G., Benfield, T., Gerstoft, J., Katzenstein, T., Moller, N. F., Pedersen, C., Ostergaard, L., Wiese, L., Nielsen, L. N., Aho, I., Viard, J. -P., Girard, P. -M., Fontas, E., Duvivier, C., Rockstroh, J., Schmidt, R., Degen, O., Stellbrink, H. J., Stefan, C., Bogner, J., Chkhartishvili, N., Gargalianos, P., Xylomenos, G., Lourida, P., Szlavik, J., Mulcahy, F., Turner, D., Burke, M., Shahar, E., Hassoun, G., Elinav, H., Haouzi, M., Elbirt, D., Sthoeger, Z. M., D'Arminio Monforte, A., Esposito, R., Mazeu, I., Mussini, C., Mazzotta, F., Gabbuti, A., Vullo, V., Lichtner, M., Zaccarelli, M., Antinori, A., Acinapura, R., Plazzi, M., Lazzarin, A., Castagna, A., Gianotti, N., Galli, M., Ridolfo, A., Uzdaviniene, V., Matulionyte, R., Staub, T., Hemmer, R., Reiss, P., Ormaasen, V., Maeland, A., Bruun, J., Knysz, B., Gasiorowski, J., Inglot, M., Horban, A., Bakowska, E., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Aksak-Was, B., Beniowski, M., Mularska, E., Smiatacz, T., Gensing, M., Jablonowska, E., Malolepsza, E., Wojcik, K., Mozer-Lisewska, I., Caldeira, L., Mansinho, K., Maltez, F., Oprea, C., Panteleev, A., Panteleev, O., Yakovlev, A., Trofimora, T., Kuzovatova, E., Borodulina, E., Vdoushkina, E., Jevtovic, D., Tomazic, J., Gatell, J. M., Miro, J. M., Moreno, S., Rodriguez, J. M., Clotet, B., Jou, A., Paredes, R., Tural, C., Puig, J., Bravo, I., Domingo, P., Gutierrez, M., Mateo, G., Sambeat, M. A., Laporte, J. M., Falconer, K., Thalme, A., Sonnerborg, A., Blaxhult, A., Flamholc, L., Scherrer, A., Weber, R., Cavassini, M., Calmy, A., Furrer, H., Battegay, M., Kuznetsova, A., Kyselyova, G., Sluzhynska, M., Gazzard, B., Johnson, A. M., Simons, E., Edwards, S., Phillips, A., Johnson, M. A., Orkin, C., Weber, J., Scullard, G., Clarke, A., Leen, C., Thiebaut, R., Burger, D., Peters, L., Matthews, C., Fischer, A. H., Bojesen, A., Raben, D., Kristensen, D., Gronborg Laut, K., Larsen, J. F., Podlekareva, D., Shepherd, L., Schultze, A., Amele, S.
المساهمون: Cozzi-lepri, A, Zangerle, R, Machala, L, Zilmer, K, Ristola, M, Pradier, C, Kirk, O, Sambatakou, H, Fätkenheuer, G, Yust, I, Schmid, P, Gottfredsson, M, Khromova, I, Jilich, D, Flisiak, R, Smidt, J, Rozentale, B, Radoi, R, Losso, M. H, Lundgren, J. D, Mocroft, A, Eurosida Study, Group, Castagna, A, Lazzarin, A, AII - Infectious diseases, APH - Aging & Later Life, Infectious diseases, Global Health, Amsterdam institute for Infection and Immunity, Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland, Clinicum, Department of Medicine, HUS Inflammation Center
المصدر: HIV Medicine, Vol. 19, No 2 (2018) pp. 102-117
EuroSIDA Study Group 2018, ' Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens ', HIV Medicine, vol. 19, no. 2, pp. 102-117 . https://doi.org/10.1111/hiv.12557
HIV MEDICINE
Cozzi-Lepri, A, Zangerle, R, Machala, L, Zilmer, K, Ristola, M, Pradier, C, Kirk, O, Sambatakou, H, Fätkenheuer, G, Yust, I, Schmid, P, Gottfredsson, M, Khromova, I, Jilich, D, Flisiak, R, Smidt, J, Rozentale, B, Radoi, R, Losso, M H, Lundgren, J D, Mocroft, A & Eurosida Study Group 2018, ' Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens ', HIV Medicine, vol. 19, no. 2, pp. 102-117 . https://doi.org/10.1111/hiv.12557
HIV medicine, 19(2), 102-117. Wiley-Blackwell
HIV Medicineمصطلحات موضوعية: Male, 0301 basic medicine, observational treatment comparison, HIV Infections, Rate ratio, propensity scores, 0302 clinical medicine, Antiretroviral Therapy, Highly Active, Neoplasms, Medicine and Health Sciences, Risk of mortality, AIDS-DEFINING, Pharmacology (medical), Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Original Research, EXPERIENCED, ddc:616, IMMUNODEFICIENCY, Incidence, Health Policy, Incidence (epidemiology), risk of cancer, Middle Aged, 3. Good health, Infectious Diseases, Anti-Retroviral Agents, SAFETY, EXPERIENCED PATIENTS, Cohort, AIDS-DEFINING CANCERS, Female, Historical Cohort, medicine.drug, Adult, Alnæmi, medicine.medical_specialty, animal structures, CANCERS, HIV INTEGRASE INHIBITORS, 030106 microbiology, Antiretroviral Therapy, survival, Risk Assessment, HIV-1-INFECTED PATIENTS, MALIGNANCIES, 03 medical and health sciences, Lyf, Raltegravir Potassium, Internal medicine, PATIENTS, medicine, Humans, COHORT, Highly Active, propensity score, Krabbamein, OPTIMIZED BACKGROUND THERAPY, business.industry, observational treatment, Raltegravir, Survival Analysis, Odds ratio, INFECTED INDIVIDUALS, comparison, 3121 General medicine, internal medicine and other clinical medicine, business
وصف الملف: application/pdf
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Axel Fun, Monique Nijhuis, Peter Messiaen, Nele Brusselaers, Linos Vandekerckhove, Annemarie M. J. Wensing
المصدر: PLoS ONE, Vol 8, Iss 1, p e52562 (2013)
PLOS ONE
PLoS ONEمصطلحات موضوعية: Oncology, HEALTH-CARE PROGRAM, Epidemiology, Integrase inhibitor, lcsh:Medicine, HIV Infections, Pharmacology, TWICE-DAILY RALTEGRAVIR, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Medicine, lcsh:Science, CO-FORMULATED ELVITEGRAVIR, Clinical Trials as Topic, Multidisciplinary, LONG-TERM EFFICACY, Elvitegravir, HIV diagnosis and management, CROSS-RESISTANCE PROFILE, Viral Load, RANDOMIZED CONTROLLED-TRIAL, Antivirals, Treatment Outcome, Dolutegravir, Infectious diseases, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Research Article, medicine.drug, medicine.medical_specialty, Clinical Research Design, Viral diseases, Microbiology, Infectious Disease Epidemiology, Pharmacotherapy, Virology, Internal medicine, Drug Resistance, Viral, Humans, Protease Inhibitors, HIV Integrase Inhibitors, Adverse effect, Biology, OPTIMIZED BACKGROUND THERAPY, Population Biology, business.industry, lcsh:R, HIV, Biology and Life Sciences, NON-INFERIORITY TRIAL, Raltegravir, Regimen, TREATMENT-EXPERIENCED PATIENTS, NAIVE HIV-1-INFECTED PATIENTS, chemistry, HIV-1, lcsh:Q, Meta-Analyses, business, Viral Transmission and Infection
وصف الملف: application/pdf
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.